ProFunds Biotechnology UltraSector Fund Investor Class
$93.83+$0.32 (+0.34%)
ProFunds Biotechnology UltraSector Fund Investor Class’s quoted price sits in the upper half of its reported 52-week range, 11.36% below the high.
NASDAQ · IMANX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 12:06 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Iman Fund Class K’s quoted price sits in the upper half of its reported 52-week range, 2.7% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Iman Fund Class K’s forward annual dividend is $0.15 per share, paid annual. The forward yield is 0.65% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The fund seeks growth of capital in accordance with Islamic principles. It achieves this by investing in common stocks and equity-related securities of domestic and foreign issuers that meet Islamic principles and whose prices the fund's investment advisor anticipates will increase over the long term. Islamic principles generally preclude investments in certain businesses like alcohol, pornography, and gambling, as well as investments in interest-bearing debt obligations.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:00 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$93.83+$0.32 (+0.34%)
ProFunds Biotechnology UltraSector Fund Investor Class’s quoted price sits in the upper half of its reported 52-week range, 11.36% below the high.
$17.26-$0.16 (-0.92%)
Matthews Emerging Markets Sust Fut Inst’s quoted price sits in the lower half of its reported 52-week range, 19.27% below the high.
$19.36-$0.05 (-0.26%)
MAI Managed Volatility Fund Investor Class’s quoted price sits in the upper half of its reported 52-week range, 0.26% below the high.
$18.07-$0.05 (-0.28%)
MAI Managed Volatility Fund’s quoted price sits in the upper half of its reported 52-week range, 0.28% below the high.
$11.00+$0.02 (+0.19%)
BlackRock MuniVest Fund II, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.73% below the high.
$10.30+$0.01 (+0.05%)
BlackRock MuniYield Quality Fund II, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.01% below the high.
$10.07-$0.07 (-0.69%)
BlackRock MuniHoldings Quality Fund II, Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.91% below the high.
$36.17+$0.18 (+0.5%)
Matthews Asia Growth Fund Insti Class’s quoted price sits in the upper half of its reported 52-week range, 19.14% below the high.